Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever as the East African country tries ...

Rwanda has said it will begin vaccine trials for the fatal Marburg virus, which has already killed at least 12 people in the ...

KIGALI, Rwanda — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said ...

Rwanda has initiated a clinical trial for a Marburg vaccine following an outbreak that has claimed 12 lives. With 46 ...

The institute said it will be sending 700 doses of the vaccine. Although there are several experimental vaccines to protect against Marburg in development, the Sabin vaccine is believed to be the ...

Of the vaccine candidates being developed, the most promising one that seems most likely to be tested if a trial moved ahead in Rwanda is the cAd3-Marburg vaccine developed by the National ...

Marburg vaccines are set to arrive in Rwanda in the coming days to help protect healthcare workers fighting an outbreak of the deadly haemorrhagic fever. The jabs, developed by the Sabin Vaccine ...

academic and government partners to speed up access to vaccine and treatment doses for trials. It has given ethical approval for these types of trials during Marburg outbreaks, and said the next ...

Several Marburg vaccines are at various stages of development. The furthest along is a candidate led by the Sabin Vaccine Institute in Washington DC that uses a modified chimpanzee adenovirus to ...

Sabin Nsanzimana, Rwanda’s health minister, said an experimental vaccine will be trialled in the country in a bid to counteract an outbreak of the deadly disease. He declined to identify the ...

Soligenix, Inc. (NASDAQ:SNGX) is developing vaccines targeting multiple filoviruses, including MarVax™, a heat stable vaccine for protection against Marburg virus. Recent events highlight the ...